|
|
Fosun Ups Tongjitang Stake to 24%
publication date: Aug 14, 2009
Shanghai Fosun Pharmaceutical (Group) Co. now owns 24% of Tongjitang Chinese Medicines (同济堂药业). The large China pharmaceutical company has been steadily buying shares since October of 2008. Just like a firefighter – who runs into buildings while everyone else is running away from them – Fosun finds Tongjitang attractive while other investors shun the stock. More details... Stock Symbols: (SHSE: 600196) (NYSE: TCM)
|
ChinaBio® Events
ChinaBio® Partnering Forum 2012May 23-24, 2012 Suzhou, China >>More events...
Partner Events
 China Healthcare Investment Conference 2012March 13-15, 2012 Shanghai, China Shanghai CEO ConferenceMarch 28-29, 2012 Shanghai, China >>More details...
Other Events
China Pharmaceutical R&D SummitApril 23-26, 2012 Shanghai, China Biosimilars Asia 2012April 23-26, 2012 Shanghai, China Vaccines China 2012April 23-26, 2012 Shanghai, China
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners
![]()
|